ONEQETF / FundFidelity Nasdaq Composite Index ETF
Verdicts genuinely change. Free email alert the moment ONEQ's does — no target price to set, unlike "Alert" above.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Fidelity Nasdaq Composite Index ETF · Fidelity Commonwealth Trust
1,030 holdings
This fund holds short positions, so exposure is counted gross — long and short both count as exposure rather than netting off, and the weights below therefore sum to 102% of net assets rather than 100%. Shares of the portfolio are shown as shares of that gross exposure.
NON-COMPLIANT 8.33% of portfolio weight is in non-compliant holdings, over the 5% threshold.
0.02% of that is conventional interest-bearing debt, identified from the fund's own filing rather than by screening an issuer. Sukuk are deliberately excluded from this test and are never counted here.
1,030 holdings, 795 matched (91% of weight). Portfolio as of 2026-08-31, filed 2026-10-26. Source: SEC Form N-PORT.
1.46% of this portfolio’s income is non-permissible — weighted across holdings, computed over 89% of portfolio weight (645 of 1030 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
53.9% compliant 29.1% questionable 8.1% non-compliant 8.8% unscreened
All holdings (1,030) · showing 1,001–1,030
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| RNTX REIN THERAPEUTICS INC | NON_COMPLIANT | 0.00% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| MAAS MAASE INC | NON_COMPLIANT | 0.00% | AAOIFI2.5% Usmani4.2% Dow Jones Islamic17.0% S&P Shariah6.1% MSCI Islamic4.2% MSCI Islamic M-Series6.1% FTSE Shariah2.4% |
| VERAXA BIOTECH HOLDING AG | UNSCREENED | 0.00% | no in-house ratios for this holding |
| BRAIIN LTD | UNSCREENED | 0.00% | no in-house ratios for this holding |
| BRID BRIDGFORD FOODS CORP | COMPLIANT | 0.00% | AAOIFI18.2% Usmani7.2% Dow Jones Islamic13.5% S&P Shariah12.3% MSCI Islamic7.1% MSCI Islamic M-Series12.3% FTSE Shariah6.2% |
| BGM BGM GROUP LTD | NON_COMPLIANT | 0.00% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| ABIOMED INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| LILA LIBERTY LATIN AMERICA LTD | NON_COMPLIANT | 0.00% | AAOIFI566.4% Usmani76.7% Dow Jones Islamic869.2% S&P Shariah870.7% MSCI Islamic76.7% MSCI Islamic M-Series870.7% FTSE Shariah72.5% |
| OPEN OPENDOOR TECHNOLOGIES INC | NON_COMPLIANT | 0.00% | AAOIFI0.3% Usmani0.3% Dow Jones Islamic0.3% S&P Shariah0.3% MSCI Islamic0.3% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| OMNIAB INC/OLD | UNSCREENED | 0.00% | no in-house ratios for this holding |
| OPEN OPENDOOR TECHNOLOGIES INC | NON_COMPLIANT | 0.00% | AAOIFI0.3% Usmani0.3% Dow Jones Islamic0.3% S&P Shariah0.3% MSCI Islamic0.3% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| OPEN OPENDOOR TECHNOLOGIES INC | NON_COMPLIANT | 0.00% | AAOIFI0.3% Usmani0.3% Dow Jones Islamic0.3% S&P Shariah0.3% MSCI Islamic0.3% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| OMNIAB INC/OLD | UNSCREENED | 0.00% | no in-house ratios for this holding |
| LGND LIGAND PHARMACEUTICALS INC | COMPLIANT | 0.00% | AAOIFI19.7% Usmani51.8% Dow Jones Islamic34.1% S&P Shariah42.6% MSCI Islamic51.8% MSCI Islamic M-Series42.6% FTSE Shariah51.5% |
| LGND LIGAND PHARMACEUTICALS INC | COMPLIANT | 0.00% | AAOIFI19.7% Usmani51.8% Dow Jones Islamic34.1% S&P Shariah42.6% MSCI Islamic51.8% MSCI Islamic M-Series42.6% FTSE Shariah51.5% |
| LGND LIGAND PHARMACEUTICALS INC | COMPLIANT | 0.00% | AAOIFI19.7% Usmani51.8% Dow Jones Islamic34.1% S&P Shariah42.6% MSCI Islamic51.8% MSCI Islamic M-Series42.6% FTSE Shariah51.5% |
| CARISMA THERAPEUTICS INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| LGND LIGAND PHARMACEUTICALS INC | COMPLIANT | 0.00% | AAOIFI19.7% Usmani51.8% Dow Jones Islamic34.1% S&P Shariah42.6% MSCI Islamic51.8% MSCI Islamic M-Series42.6% FTSE Shariah51.5% |
| SATSUMA PHARMACEUTICALS INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| KINNATE BIOPHARMA INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| AVADEL PHARMACEUTICALS PLC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| AZN ASTRAZENECA PLC | COMPLIANT | 0.00% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| OZON HOLDINGS PLC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| CLEMENTIA PHARMACEUTICALS INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| APPLIED GENETIC TECHNOLOGIES CORP | UNSCREENED | 0.00% | no in-house ratios for this holding |
| CINCOR PHARMA INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| DOVA PHARMACEUTICALS INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| MIRATI THERAPEUTICS INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| SNY SANOFI | COMPLIANT | 0.00% | AAOIFI20.8% Usmani14.7% Dow Jones Islamic38.1% S&P Shariah38.6% MSCI Islamic14.7% MSCI Islamic M-Series38.6% FTSE Shariah14.7% |
| RO.SW ROCHE HOLDING AG | COMPLIANT | 0.00% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
The published standards disagree about this fund by 22 points of portfolio weight — 83.0% of it passes AAOIFI, 61.1% passes MSCI Islamic. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 83.0% ratios fail on 7.5% 11.8% not rated under AAOIFI
ratios pass on 75.5% ratios fail on 14.4% 12.4% not rated under Usmani
ratios pass on 81.7% ratios fail on 8.0% 12.6% not rated under Dow Jones Islamic
ratios pass on 82.0% ratios fail on 7.8% 12.6% not rated under S&P Shariah
ratios pass on 61.1% ratios fail on 20.6% 20.6% not rated under MSCI Islamic
ratios pass on 81.6% ratios fail on 8.1% 12.6% not rated under MSCI Islamic M-Series
ratios pass on 73.8% ratios fail on 15.8% 12.8% not rated under FTSE Shariah
780 of 1,030 listed holdings carry our own per-methodology verdicts (93% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 678 (91% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
| Non-compliant holding | Weight |
|---|---|
| TMUS T-MOBILE US INC | 0.42% |
| CME CME GROUP INC | 0.22% |
| CMCSA COMCAST CORP | 0.20% |
| HOOD ROBINHOOD MARKETS INC | 0.18% |
| DDOG DATADOG INC | 0.17% |
| ABNB AIRBNB INC | 0.17% |
| WBD WARNER BROS DISCOVERY INC | 0.15% |
| HON HONEYWELL INTERNATIONAL INC | 0.14% |
| PCAR PACCAR INC | 0.14% |
| AEP AMERICAN ELECTRIC POWER CO INC | 0.14% |
Methodology breakdown computing — it will appear here on its own.
Trade setup
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Why this signal?
The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.
Fidelity Nasdaq Composite Index ETF (ONEQ) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
🕌 In-house Compliance Research
Computing the full ratio and business-activity breakdown for ONEQ — this runs off the critical path so the page paints first. It will appear here on its own.
| Investor | Firm | Position | Weight | As of |
|---|---|---|---|---|
| Ken Fisher | Fisher Asset Management | $59M | 0.0% | 2026-06-30 |
From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 30.10 | NEUTRAL |
| Stochastic %K (14) | 1.72 | BUY |
| CCI (20) | -195.30 | BUY |
| Williams %R (14) | -98.28 | BUY |
| MACD (12,26,9) | -0.71 | SELL |
| ROC (10) | -6.51 | SELL |
| Momentum (10) | -6.67 | SELL |
| EMA (10) | 100.90 | SELL |
| SMA (10) | 101.44 | SELL |
| EMA (20) | 102.50 | SELL |
| SMA (20) | 103.31 | SELL |
| EMA (30) | 103.20 | SELL |
| SMA (30) | 104.52 | SELL |
| EMA (50) | 103.56 | SELL |
| SMA (50) | 104.39 | SELL |
| EMA (100) | 102.69 | SELL |
| SMA (100) | 103.24 | SELL |
| EMA (200) | 98.86 | SELL |
| SMA (200) | 98.65 | SELL |
About Fidelity Nasdaq Composite Index ETF
The fund normally invests at least 80% of assets in common stocks included in the index. The advisor uses statistical sampling techniques that take into account such factors as capitalization, industry exposures, dividend yield, price/earnings (P/E) ratio, price/book (P/B) ratio, and earnings growth to create a portfolio of securities listed in the Nasdaq Composite Index® that have a similar investment profile to the entire index.
Background via Yahoo Finance — informational, not part of the verdict.
Average — needs more confirmation before sizing up
SMC — Top Down
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BEARISH | 43 |
| ⏰ 4H | BEARISH | 39 |
| 🕐 1H | BULLISH | 98 |
| ⏱ 15-Min | BEARISH | 130 |
| ⏲ 5-Min | BULLISH | 234 |
Momentum & Volume
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
Peer Movement
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
Before you act on this
The questions worth asking about any verdict on this page, answered plainly.
Is a fund screened on its name?
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
What does unrated weight mean?
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
Does the issuer's board make it compliant?
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
How often is this re-screened?
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Compare with
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Still fetching insider filings — it ran past this page's budget, so the page painted without waiting. The fetch is still running; reload in a moment and it will be here.
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-10-27 · Asset managers net 923449 (+22072)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.